Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/354
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMalham, Gregory-
dc.contributor.otherEllis, Ngaire-
dc.contributor.otherParker, Rhiannon-
dc.contributor.otherSeex, Kevin-
dc.date2012-11-
dc.date.accessioned2015-09-09T02:55:01Z-
dc.date.available2015-09-09T02:55:01Z-
dc.date.issued2012-11-
dc.identifier.citationScientificWorldJournal. 2012;2012:246989en_US
dc.identifier.issn2356-6140en_US
dc.identifier.issn1537-744Xen_US
dc.identifier.urihttp://hdl.handle.net/11434/354-
dc.description.abstractIntroduction. The lateral transpsoas approach for lumbar interbody fusion (XLIF) is gaining popularity. Studies examining a surgeon's early experience are rare. We aim to report treatment, complication, clinical, and radiographic outcomes in an early series of patients. Methods. Prospective data from the first thirty patients treated with XLIF by a single surgeon was reviewed. Outcome measures included pain, disability, and quality of life assessment. Radiographic assessment of fusion was performed by computed tomography. Results. Average follow-up was 11.5 months, operative time was 60 minutes per level and blood loss was 50 mL. Complications were observed: clinical subsidence, cage breakage upon insertion, new postoperative motor deficit and bowel injury. Approach side-effects were radiographic subsidence and anterior thigh sensory changes. Two patients required reoperation; microforaminotomy and pedicle screw fixation respectively. VAS back and leg pain decreased 63% and 56%, respectively. ODI improved 41.2% with 51.3% and 8.1% improvements in PCS and MCS. Complete fusion (last follow-up) was observed in 85%. Conclusion. The XLIF approach provides superior treatment, clinical outcomes and fusion rates compared to conventional surgical approaches with lowered complication rates. Mentor supervision for early cases and strict adherence to the surgical technique including neuromonitoring is essential.en_US
dc.publisherHindawi Publishing Corporationen_US
dc.subjectLateral Transpsoasen_US
dc.subjectLumbar Interbody Fusionen_US
dc.subjectXLIFen_US
dc.subjectTreatment Outcomesen_US
dc.subjectComplication Outcomesen_US
dc.subjectClinical Outcomesen_US
dc.subjectRadiographic Outcomesen_US
dc.subjectEarly Experience of Surgeonsen_US
dc.subjectRecovery of Functionen_US
dc.subjectDisability Outcomesen_US
dc.subjectComputed Tomographyen_US
dc.subjectQoLen_US
dc.subjectQuality of Life Assessmenten_US
dc.subjectNeuromonitoringen_US
dc.subjectActivities of Daily Livingen_US
dc.subjectPain Managementen_US
dc.subjectPain Assessmenten_US
dc.subjectSpinal Fusionen_US
dc.subjectSpinal Diseasesen_US
dc.subjectComputed Tomographyen_US
dc.subjectNeurosciences Clinical Institute, Epworth HealthCare, Victoria, Australia-
dc.titleClinical outcome and fusion rates after the first 30 extreme lateral interbody fusionsen_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1100/2012/246989en_US
dc.identifier.journaltitleThe Scientific World Journalen_US
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/23213282en_US
dc.description.affiliatesDepartment of Neurosurgery, Macquarie University, Sydney, NSW 2109, Australiaen_US
dc.type.studyortrialRetrospective studiesen_US
dc.type.contenttypeTexten_US
Appears in Collections:Diagnostic Services
Neurosciences

Files in This Item:
File Description SizeFormat  
TSWJ2012-246989.pdfMain article950.89 kBAdobe PDFView/Open


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.